Human diseases that HBRI researchers work on are complex and require sophisticated strategies to defeat. HBRI’s multi-disciplinary approach examines the mechanisms behind the disease and leads to new insights to create medications to treat the disease. To maximize the potential of HBRI’s advanced technology and drug candidates to benefit patients, HBRI seeks highly collaborative, long-term relationships with industry. These relationships have proven mutually beneficial to both HBRI and industry. As partners, HBRI has helped develop numerous drugs that are in clinical use today.
HBRI’s industry partners can gain access to critical technology and intellectual property and are able to leverage significant external funding that supports research at HBRI.